Advertisement

Effects of Addictive Substances During Pregnancy and Infancy and Their Analysis in Biological Materials

  • Justyna Płotka
  • Sylwia Narkowicz
  • Żaneta Polkowska
  • Marek Biziuk
  • Jacek Namieśnik
Chapter
Part of the Reviews of Environmental Contamination and Toxicology book series (RECT, volume 227)

Abstract

Addictive substance use is most prevalent in people who are of reproductive-age. In a national prevalence survey performed among pregnant women aged 15–44 years, 10.8 % reported using alcohol, 17 % reported smoking during pregnancy, and 4.4 % reported abusing one or more illicit substances (Fig. 1) (SAMHSA 2011). Substance abuse for a pregnant woman is twice as dangerous as for others, because:

Keywords

Pregnant Woman Illicit Drug Amniotic Fluid Drug Exposure Nicotine Replacement Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Justyna Płotka and Sylwia Narkowicz express their gratitude for financial support received from the Human Capital Programme (POKL.04.01.01-00-368/09).

References

  1. Al-Saleh I, Shinwari N, Mashhour A, Mohamed Gel D, Rabah A (2011) Heavy metals (lead, cadmium and mercury) in maternal, cord blood and placenta of healthy women. Int J Hyg Environ Health 214:79–101CrossRefGoogle Scholar
  2. Anderson M, Elk R, Andres RL (1997) Social, ethical and practical aspects of perinatal substance use. J Subst Abuse Treat 14:481–486CrossRefGoogle Scholar
  3. Baranowski J, Pochopień G, Baranowska I (1998) Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. J Chromatogr B 707:317–321CrossRefGoogle Scholar
  4. Borgerdinga M, Klusb H (2005) Analysis of complex mixtures: cigarette smoke. Exp Toxicol Pathol 57:43–73CrossRefGoogle Scholar
  5. Chen C, Cho SI, Damokosh AI, Chen D, Li G, Wang X, Xu X (2000) Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect 108:1019–1022CrossRefGoogle Scholar
  6. Daley M, Argeriou M, McCarty D (1998) Substance abuse treatment for pregnant women: a window of opportunity? Addict Behav 23:239–249CrossRefGoogle Scholar
  7. De Castro A, Concheiro M, Shakleya DM, Huestis MA (2009) Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. J Anal Toxicol 33:243–252CrossRefGoogle Scholar
  8. Dejmek J, Solansky I, Podrazilová K, Srám RJ (2002) The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth. Environ Health Perspect 110:601–610CrossRefGoogle Scholar
  9. Eskenazi B, Castorina R (1999) Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 107:991–1000CrossRefGoogle Scholar
  10. Esteban M, Castaño A (2009) Non-invasive matrices in human biomonitoring: a review. Environ Int 35:438–449CrossRefGoogle Scholar
  11. Eyler FD, Behnke M, Wobie K, Garvan CW, Tebbett I (2005) Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol 27:677–687CrossRefGoogle Scholar
  12. Falcon M, Valero F, Pellegrini M, Rotolo MC, Scaravelli G, Joya J, Vall O, García Algar O, Luna A, Pichini S (2010) Exposure to psychoactive substances in women who request voluntary termination of pregnancy assessed by serum and hair testing. Forensic Sci Int 196:22–26CrossRefGoogle Scholar
  13. Finnegan LP (1994) Perinatal morbidity and mortality in substance using families: effects and intervention strategies. Bull Narcotics 46:19–43Google Scholar
  14. Gilmour MI, Jaakkola MS, London SL, Nel AE, Rogers CA (2006) How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ Health Perspect 114:627–633CrossRefGoogle Scholar
  15. Gray T, Huestis M (2007) Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 388:1455–1465CrossRefGoogle Scholar
  16. Gray TR, Eiden RD, Leonar KE, Connors GJ, Shisler S, Huestis MA (2010) Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem 56:1442–1450CrossRefGoogle Scholar
  17. Gray TR, Shakleya DM, Huestis MA (2008) Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J Chromatogr B 863:107–114CrossRefGoogle Scholar
  18. Hakkola J, Pasanen M, Hukkanen J, Pelkonen O, Mäenpää J, Edwards RJ, Boobis AR, Raunio H (1996) Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol 51:403–411CrossRefGoogle Scholar
  19. Huestis MA, Choo RE (2002) Drug abuse’s smallest victims: in utero drug exposure. Forensic Sci Int 128:20–30CrossRefGoogle Scholar
  20. Huestis MA, Cone EJ (1998) Alternative testing matrices. In: Karch SB (ed) Drug abuse handbook, 2nd edn. CRC Press, Boca Raton, FL, pp 799–857Google Scholar
  21. Jauniaux E, Burton GJ (2007) Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev 83:699–706CrossRefGoogle Scholar
  22. Jones J (1974) Nutrition, drugs and their interrelations. PA Health 35:3Google Scholar
  23. Joya X, Pujadas M, Falcón M, Civit E, Garcia-Algar O, Vall O, Pichini S, Luna A, De la Torre R (2010) Gas chromatography–mass spectrometry assay for the simultaneous quantification of drugs of abuse in human placenta at 12th week of gestation. Forensic Sci Int 196:38–42CrossRefGoogle Scholar
  24. Kissin WB, Svikis DS, Morgan GD, Haug NA (2001) Characterizing pregnant drug-dependent women in treatment and their children. J Subst Abuse Treat 21:27–34CrossRefGoogle Scholar
  25. Kulaga V, Shor S, Koren G (2010) Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder. Alcohol 44:615–621CrossRefGoogle Scholar
  26. Larkby C, Day N (1997) The effects of prenatal alcohol exposure. Alcohol Health Res World 21:192–198Google Scholar
  27. Leino O, Kiviranta H, Karjalainen AK, Kronberg-Kippilä C, Sinkko H, Larsen EH, Virtanen S, Tuomisto JT (2011) Pollutant concentrations in placenta. Food Chem Toxicol 54:59–69CrossRefGoogle Scholar
  28. Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, DeVane CL, Stowe ZN (2006) Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry 163:145–147CrossRefGoogle Scholar
  29. Lozano J, García-Algar O, Vall O, De la Torre R, Scaravelli G, Pichini S (2007) Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit 29:711–734CrossRefGoogle Scholar
  30. López P, Bermejo AM, Tabernero MJ, Fernández P, Alvarez I (2007) Determination of cocaine and heroin with their respective metabolites in meconium by gas chromatography–mass spectrometry. J Appl Toxicol 27:464–471CrossRefGoogle Scholar
  31. Marchei E, Escuder D, Pallas CR, Garcia-Algar O, Gómez A, Friguls B, Pellegrini M, Pichini S (2011) Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 55:309–316CrossRefGoogle Scholar
  32. Marx JA, Hockberger RS, Wall RM, Adams J (2002) Rosen’s emergency medicine: concepts and clinical practice, 5th edn. CV Mosby, St. Louis, pp 2396–2400Google Scholar
  33. Miller WH, Hyatt MC (1992) Perinatal substance abuse. Am J Drug Alcohol Abuse 18:247–261CrossRefGoogle Scholar
  34. Myllynen P, Pasanen M, Pelkonen O (2005) Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 26:361–371CrossRefGoogle Scholar
  35. Myren M, Mose T, Mathiesen L, Knudsen LE (2007) The human placenta—an alternative for studying fetal exposure. Toxicol Vitro 21:1332–1340CrossRefGoogle Scholar
  36. Narkowicz S, Polkowska Ż, Namieśnik J (2012) Analysis of markers of exposure to constituents of environmental tobacco smoke (ETS). Crit Rev Anal Chem 42:16–37CrossRefGoogle Scholar
  37. Niemann RA, Anderson DL (2008) Determination of iodide and thiocyanate in powdered milk and infant formulaby on-line enrichment ion chromatography with photodiode array detection. J Chrom A 1200:193–197CrossRefGoogle Scholar
  38. Nikolaou PD, Papoutsis II, Maravelias CP, Spiliopoulou CA, Pistos CM, Calokerinos AC, Atta-Politou J (2008) Development and validation of an EI-GC-MS method for the determination of methadone and its major metabolites (EDDP and EMDP) in human breast milk. J Anal Toxicol 32:478–484CrossRefGoogle Scholar
  39. Ostrea EM Jr, Hernandez JD, Bielawski DM, Kan JM, Leonardo GM, Abela MB, Church MW, Hannigan JH, Janisse JJ, Ager JW, Sokol RJ (2006) Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res 30:1152–1159CrossRefGoogle Scholar
  40. Otero C, Boles S, Young NK, Dennis K (2004) Methamphetamine: addiction, treatment, outcomes and implications. U.S. Department of Health and Human Services, SAMHSA, Rockville, MDGoogle Scholar
  41. Pellegrini M, Marchei E, Rossi S, Vagnarelli F, Durgbanshi A, Garcĺa-Algar Ó, Vall O, Pichini S (2007) Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk. Rapid Commun Mass Spectrom 21:2693–2703CrossRefGoogle Scholar
  42. Phibbs CS, Bateman DA, Schwartz RM (1991) The neonatal costs of maternal cocaine use. J Am Med Assoc 266:1521–1526CrossRefGoogle Scholar
  43. Pichini S, Altieri I, Pellegrini M, Pacifici R, Zuccaro P (1997) The analysis of nicotine in infants' hair for measuring exposure to environmental tobacco smoke. Forensic Sci Int 84:253–258CrossRefGoogle Scholar
  44. Polkowska Ż, Kozłowska K, Witkowska E, Namieśnik J (2004) Materiały biologiczne pochodzenia ludzkiego jako źródło informacji o narażeniu człowieka na środowiskowe czynniki chemiczne. In: Collective work. Bioanalityka w ocenie zanieczyszczeń środowiska. CEEAM, Gdansk, pp 75–107Google Scholar
  45. Quertemont E, Didone V (2006) Role of acetaldehyde in mediating the pharmacological and behavioral effects of alcohol. Alcohol Res Helth 29:258–266Google Scholar
  46. Rogers JM (2009) Tobacco and pregnancy. Reprod Toxicol 28:152–160CrossRefGoogle Scholar
  47. SAMHSA (2011) Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11–4658. Rockville, MD: Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm. Accessed 7 June 2012
  48. Scharnberg K (2003) Prosecutors targeting pregnant drug users; some fear women will shun treatment. Chi Trib Nov 23:C1Google Scholar
  49. Schütz H, Paine A, Erdmann F, Weiler G, Verhoff MA (2006) Immunoassays for drug screening in urine. Forensic Sci Med Pathol 2:75–83CrossRefGoogle Scholar
  50. Shakleya DM, Dams R, Choo RE, Jones H, Huestis MA (2010) Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment. J Anal Toxicol 34:17–25CrossRefGoogle Scholar
  51. Van der Aa EM, Peereboom-Stegeman JH, Noordhoek J, Gribnau FW, Russel FG (1998) Mechanisms of drug transfer across the human placenta. Pharm World Sci 20:139–148CrossRefGoogle Scholar
  52. Vinner E, Vignau J, Thibault D, Codaccioni X, Brassart C, Humbert L, Lhermitte M (2003) Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome. Ther Drug Monit 25:421–432CrossRefGoogle Scholar
  53. Vogel A (1997) Neurodevelopment: cocaine wreaks subtle damage on developing brains. Science 278:38–39CrossRefGoogle Scholar
  54. Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762–768CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Justyna Płotka
    • 1
  • Sylwia Narkowicz
    • 1
  • Żaneta Polkowska
    • 1
  • Marek Biziuk
    • 1
  • Jacek Namieśnik
    • 1
  1. 1.Department of Analytical Chemistry, Chemical FacultyGdansk University of Technology (GUT)GdańskPoland

Personalised recommendations